The brain may be about to have its Ozempic moment
ONE PEPTIDE has recently transformed medicine. Drugs based on glucagon-like peptide-1 (GLP-1), a hormone released by the gut after a meal, began as treatments for diabetes before proving remarkably good at helping people shed weight. They have since shown benefits in the fields of heart disease, kidney disease, sleep apnoea and other ailments. Drugmakers are now betting that others, the orexins, could follow a similar path.
Already have an account?Log in
Continue with a free trial
Get full access to our independent journalism for free
Or create a free account to unlock just this article
readers loved this